Search

Search Constraints

You searched for: Author/Creator Clackson, Tim

Search Results

1. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

2. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

3. Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer. (15th January 2023)

4. Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study. (21st May 2013)